MERIDIAN BIOSCIENCE INC 4
4 · MERIDIAN BIOSCIENCE INC · Filed Apr 1, 2016
Insider Transaction Report
Form 4
LUEKE MELISSA
VP, CFO
Transactions
- Award
Stock Options (Right to Buy)
2016-03-24+12,500→ 12,500 totalExercise: $19.56Exp: 2026-03-24→ Common Stock (12,500 underlying)
Holdings
- 156,489
Common Stock
Footnotes (1)
- [F1]These options are awarded under the 2012 Stock Incentive Plan in connection with the Company's acquisition of Magellan Diagnostics, Inc. and vest in four equal installments from the date of grant (i.e., 25% per year until fully vested on March 24, 2020).